HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Reata Pharmaceuticals, Inc. (RETA) Investors to Lead Plaintiff Opportunity in Securities Fraud Class Action
23 déc. 2021 10h03 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...